AIMS Allergy and Immunology

Scope & Guideline

Advancing the Frontiers of Allergy and Immunology

Introduction

Welcome to the AIMS Allergy and Immunology information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of AIMS Allergy and Immunology, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN2575-615x
PublisherAMER INST MATHEMATICAL SCIENCES-AIMS
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationAIMS ALLERGY IMMUNOL / AIMS Allergy Immunol.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPO BOX 2604, SPRINGFIELD, MO 65801-2604, UNITED STATES

Aims and Scopes

The journal AIMS Allergy and Immunology focuses on advancing the understanding of allergic and immunological disorders, emphasizing innovative research methodologies and interdisciplinary approaches.
  1. Allergy Mechanisms and Treatments:
    The journal publishes research on the underlying mechanisms of allergic reactions, including cellular and molecular pathways, and the development of novel therapeutic strategies.
  2. Immunological Responses and Disorders:
    It covers a wide range of immunological disorders, exploring the immune system's role in various diseases, including autoimmune conditions and infectious diseases.
  3. Vaccine Research and Development:
    With a focus on vaccine efficacy and safety, the journal discusses adverse reactions and immunological responses to vaccines, particularly in the context of emerging infectious diseases like COVID-19.
  4. Environmental and Lifestyle Factors:
    Research exploring how environmental allergens, lifestyle, and dietary influences affect allergic and immunological responses is a core area of the journal.
  5. Clinical Studies and Case Reports:
    The journal includes clinical research and case studies that provide insights into the diagnosis, management, and treatment of allergic conditions and immunological disorders.
Recent publications in AIMS Allergy and Immunology highlight emerging trends and themes that are gaining traction, reflecting both current health concerns and advancements in research methodologies.
  1. COVID-19 Related Immunology:
    There is a significant increase in research focusing on the immunological aspects of COVID-19, including vaccine responses, long-term effects, and the relationship between COVID-19 and allergic conditions.
  2. Multi-Omics Approaches in Allergy Research:
    The use of multi-omics technologies (genomics, proteomics, metabolomics) to understand allergic diseases and their mechanisms is trending, providing comprehensive insights into patient-specific responses.
  3. MicroRNA and Epigenetics in Allergy and Immunology:
    Emerging interest in the role of microRNAs and epigenetic factors in regulating immune responses and allergic diseases indicates a shift towards understanding complex regulatory mechanisms.
  4. Food Allergies and Dietary Influences:
    Research on food allergies, their mechanisms, and dietary interventions is gaining prominence, reflecting increasing public health concerns and the need for effective management strategies.
  5. Innovative Vaccine Development Strategies:
    The journal is seeing a rise in studies related to novel vaccine technologies and strategies, particularly in response to the challenges posed by emerging pathogens and variants.

Declining or Waning

Over recent years, certain themes within AIMS Allergy and Immunology have shown a decline in prominence, reflecting shifting research priorities and emerging areas of interest.
  1. Traditional Allergy Testing Methods:
    Research focusing on conventional allergy testing methods, such as skin prick tests and specific IgE measurements, has decreased, possibly due to advancements in molecular diagnostics.
  2. Basic Immunology without Clinical Application:
    There appears to be a reduction in purely basic immunological research that does not connect to clinical applications or therapeutic outcomes, as there is a growing emphasis on translational research.
  3. Non-Specific Immunotherapy Approaches:
    Interest in older, less targeted immunotherapy approaches has declined, with a shift towards more personalized and biologically-based therapies.

Similar Journals

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Exploring Innovative Solutions for Allergic Diseases.
Publisher: KARGERISSN: 1018-2438Frequency: 12 issues/year

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, published by KARGER, is a distinguished journal dedicated to advancing the field of immunology and allergy research. With an ISSN of 1018-2438 and an E-ISSN of 1423-0097, this journal has been a vital resource since its inception in 1950, continuing to publish influential articles through 2024. Hailing from Switzerland, it holds an important position within the Q3 category in Immunology and Allergy and Q2 in miscellaneous Medicine, reflecting its growing impact in the scientific community. The Scopus rankings showcase its relevance, with a 52nd percentile in Immunology and Allergy and 45th in Immunology and Microbiology. Although not an open-access journal, it plays a critical role in disseminating significant findings and innovations in the understanding of allergic diseases and immunological responses. The INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY is essential for researchers, clinicians, and students eager to stay at the forefront of allergy and immunology developments.

Central European Journal of Immunology

Connecting Global Minds in Immunology
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 1426-3912Frequency: 4 issues/year

Central European Journal of Immunology is a premier publication dedicated to advancing the field of immunology and allergy research. Established in 1996 and published by TERMEDIA PUBLISHING HOUSE LTD, this open access journal has consistently provided a platform for innovative research and comprehensive reviews since its transition to open access in 2002. With an ISSN of 1426-3912 and E-ISSN of 1644-4124, it embraces a global readership while being rooted in Poland. The journal, with a notable Q3 ranking in both the categories of immunology and allergy in 2023, positions itself within the competitive landscape of scientific discourse, as reflected in its Scopus rankings. Designed for researchers, professionals, and students, the Central European Journal of Immunology not only disseminates significant findings but also fosters collaboration and innovation in the immunological sciences, making it a vital resource for those seeking to stay current in this rapidly evolving field.

Clinical and Experimental Vaccine Research

Fostering collaboration in the realm of immunology.
Publisher: KOREAN VACCINE SOCISSN: 2287-3651Frequency: 2 issues/year

Clinical and Experimental Vaccine Research, an esteemed journal published by the Korean Vaccine Society, serves as a vital platform for disseminating groundbreaking research in the fields of Immunology, Infectious Diseases, and Public Health. Since its inception in 2012, this open-access journal has been committed to advancing knowledge and fostering collaboration among professionals dedicated to vaccine development and evaluation. With an impactful presence and a Q3 ranking in several categories on the Scopus index, it reflects a robust commitment to quality, evidenced by its placement within the 41st to 59th percentiles across multiple disciplines related to medicine and health. Situated in Seoul, South Korea, at the Department of Pediatrics, Yonsei University Severance Children's Hospital, the journal not only provides a crucial resource for researchers and practitioners but also enhances the global discourse on vaccination strategies and public health interventions. By contributing to the ongoing dialogue in vaccine research, this journal plays an essential role in shaping future health policies and practices.

ALLERGY

Leading the Charge in Allergy Research and Education.
Publisher: WILEYISSN: 0105-4538Frequency: 12 issues/year

ALLERGY is a leading international journal published by WILEY, dedicated to advancing the understanding of allergic diseases and immunology. With an ISSN of 0105-4538 and an E-ISSN of 1398-9995, this esteemed journal has been at the forefront of the field since its inception in 1948 and continues to publish high-quality research up until 2024. Positioned in the Q1 category for both Immunology and Allergy, ALLERGY ranks impressively within the top percentiles of its categories, underscoring its significant impact, as reflected in its Scopus rankings (#11 out of 233 in Immunology and Allergy, and #14 out of 236 in Immunology and Microbiology). Researchers and practitioners accessing this journal can expect a rigorous selection of peer-reviewed articles that address current challenges, innovative therapies, and advancements in the immunological sciences. Although it is not an open-access journal, ALLERGY remains vital for academics, healthcare professionals, and students alike, fostering a deeper understanding of the mechanisms and treatments associated with allergies.

VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY

Transforming animal health through rigorous immunology studies.
Publisher: ELSEVIERISSN: 0165-2427Frequency: 14 issues/year

Veterinary Immunology and Immunopathology is a premier journal published by Elsevier, dedicated to advancing the field of veterinary science through rigorous investigations into the immunological mechanisms that underpin disease resistance, pathogenesis, and therapeutic interventions in animals. With an established history since 1979, this journal has consistently provided a platform for high-quality research, bridging the gap between immunology and veterinary medicine. The current impact factor reflects its significance within the field, particularly noted for its Q3 ranking in Immunology and Q2 in miscellaneous Veterinary categories as of 2023. The journal caters to a diverse audience, from seasoned researchers to students, by publishing original research, reviews, and case studies that explore pivotal topics such as vaccine development, immune response in various species, and the role of genetics in immunological disorders. Notably, it is indexed in Scopus, where it ranks in the top percentile of veterinary science disciplines, enhancing its visibility and impact within the scientific community. For those seeking to stay at the forefront of veterinary immunology, this journal is an invaluable resource.

ALLERGOLOGIE

Advancing Knowledge in Allergic Diseases
Publisher: DUSTRI-VERLAG DR KARL FEISTLEISSN: 0344-5062Frequency: 12 issues/year

ALLERGOLOGIE is a prominent academic journal dedicated to the field of immunology and allergy, published by DUSTRI-VERLAG DR KARL FEISTLE in Germany. Since its inception in 1978, the journal has provided a vital platform for researchers, clinicians, and students to disseminate their findings, share insights, and foster advancements in the understanding of allergic diseases and immunological responses. With an ISSN of 0344-5062 and an E-ISSN of the same number, it is a respected source within its category, currently ranked in the 2023 Q4 of the Scopus metrics in immunology and allergy, reflecting its commitment to quality and scholarly rigor. Although not fully open access, ALLERGOLOGIE makes significant contributions to the dialogue on allergy-related topics, encouraging engagement from its readership through a diverse array of articles that span from clinical trials to innovative research methods. This journal continues to be an essential resource for anyone involved in the pursuit of knowledge in allergy and immunology.

Egyptian Journal of Pediatric Allergy and Immunology

Connecting researchers and practitioners for a healthier future.
Publisher: EGYPTIAN SOC PEDIATRIC ALLERGY & IMMUNOLOGYISSN: 1687-1642Frequency: 2 issues/year

Welcome to the Egyptian Journal of Pediatric Allergy and Immunology, a leading academic platform dedicated to the advancement of knowledge in the field of pediatric allergy and immunology. Published by the prestigious Egyptian Society of Pediatric Allergy & Immunology, this journal aims to address the pressing challenges and breakthroughs in the diagnosis, treatment, and management of allergic diseases in children. As a crucial resource for researchers, healthcare professionals, and students, it focuses on disseminating high-quality, peer-reviewed articles that contribute to the global understanding of allergic conditions and immunological responses in pediatric populations. Although the journal is currently not an Open Access publication, it provides a valuable gateway to research findings that can shape clinical practice and influence future investigations. With an emphasis on contributing to improved healthcare outcomes for children suffering from allergy and immunology disorders, the Egyptian Journal of Pediatric Allergy and Immunology stands out as an essential reference in the field.

Allergy Asthma and Clinical Immunology

Advancing knowledge in allergy and asthma research.
Publisher: BMCISSN: 1710-1492Frequency: 1 issue/year

Allergy Asthma and Clinical Immunology, a pioneering open access journal published by BMC, has been at the forefront of immunological research since its inception in 2005. With an ISSN of 1710-1492, this UK-based journal has established a significant presence in the fields of Immunology, Allergy, and Pulmonary and Respiratory Medicine, achieving notable quartile rankings such as Q2 in Immunology and Allergy in 2023. It plays a crucial role in disseminating high-quality research that advances our understanding of allergy and asthma, making substantial contributions to clinical practices and public health. The journal embraces the principles of Open Access, allowing researchers, professionals, and students from around the globe to access its content freely, thus facilitating knowledge sharing and collaboration within the scientific community. As it converges towards 2024, Allergy Asthma and Clinical Immunology continues to attract impactful studies that drive innovation and improve patient care in the face of rapidly evolving challenges in immunological health.

Alergologia Polska-Polish Journal of Allergology

Illuminating the pathways of allergy mechanisms and treatments.
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 2353-3854Frequency: 4 issues/year

Alergologia Polska - Polish Journal of Allergology, published by TERMEDIA PUBLISHING HOUSE LTD, is a distinguished academic journal dedicated to advancing the field of allergy research and treatment. With the ISSN 2353-3854, this journal serves as an essential resource for professionals, researchers, and students alike, offering a platform for the dissemination of novel findings and comprehensive reviews in allergic diseases. The journal emphasizes open access to ensure widespread availability and engagement within the scientific community. Alergologia Polska aims to enhance the understanding of allergy mechanisms, diagnostics, and management strategies, fostering collaboration and innovation among experts in the field. Set against the vibrant backdrop of Poznań, Poland, this publication not only highlights clinical and experimental research but also promotes interdisciplinary discussions that are pivotal for tackling complex allergic conditions globally.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA

Pioneering Research in Immunology and Allergy for a Healthier Future
Publisher: CODON PUBLICATIONSISSN: 0301-0546Frequency: 6 issues/year

ALLERGOLOGIA ET IMMUNOPATHOLOGIA is a distinguished academic journal dedicated to the field of immunology and allergy, published by CODON PUBLICATIONS, based in Singapore. With its ISSN 0301-0546 and E-ISSN 1578-1267, this journal aims to provide an open platform for researchers and practitioners to share their findings, emphasizing topics related to immunopathology and respiratory health. Covering a broad scope from 1973 to 2024, it currently holds a notable position in several category quartiles, including Q3 in Immunology and Allergy, and Q3 in Pulmonary and Respiratory Medicine as of 2023. Despite the absence of an open access option, the journal maintains an essential role in disseminating pivotal research, reflected in its Scopus rankings that position it within the core of its discipline. With an impact factor acknowledging the significance of its contributions, ALLERGOLOGIA ET IMMUNOPATHOLOGIA continues to be a vital resource for ongoing education and advancement in immunological and allergic research.